BMPR2 and pulmonary arterial hypertension: In our relatively small cohort of tested patients, PAH patients carrying a BMPR2 mutation seemed equally prone to develop hemoptysis as BMPR2 negative patients, despite worse hemodynamics and a trend towards more bronchial artery hypertrophy.